相似文献
1
Proton pump inhibitor failure in gastro-oesophageal reflux disease: a perspective aided by the Gartner hype cycle.
Clin Med (Lond). 2017 Apr;17(2):132-136. doi: 10.7861/clinmedicine.17-2-132.
2
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD002095. doi: 10.1002/14651858.CD002095.pub5.
3
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Cochrane Database Syst Rev. 2010 Nov 10(11):CD002095. doi: 10.1002/14651858.CD002095.pub4.
4
Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey.
Clin Drug Investig. 2011 Oct 1;31(10):703-15. doi: 10.2165/11595480-000000000-00000.
5
Treatment of PPI-resistant gastro-oesophageal reflux: A systematic review.
Arab J Gastroenterol. 2018 Jun;19(2):51-55. doi: 10.1016/j.ajg.2018.02.007. Epub 2018 Jun 20.
6
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Cochrane Database Syst Rev. 2006 Jul 19(3):CD002095. doi: 10.1002/14651858.CD002095.pub3.
7
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Cochrane Database Syst Rev. 2001(4):CD002095. doi: 10.1002/14651858.CD002095.
8
Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.
Gut. 2012 Apr;61(4):501-6. doi: 10.1136/gutjnl-2011-300798. Epub 2011 Oct 13.
9
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002095. doi: 10.1002/14651858.CD002095.pub2.
10
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Cochrane Database Syst Rev. 2000(2):CD002095. doi: 10.1002/14651858.CD002095.
引用本文的文献
1
[Artificial intelligence in radiology : From the Gartner Hype Cycle to Amara's Law].
Radiologie (Heidelb). 2024 Oct;64(10):749-751. doi: 10.1007/s00117-024-01362-5. Epub 2024 Sep 24.
2
Risk Factors for Gastroesophageal Reflux Disease in Saudi Arabia.
Gastroenterology Res. 2017 Oct;10(5):294-300. doi: 10.14740/gr906w. Epub 2017 Oct 26.
3
'Evolution, not revolution, at the changing of the Guard'.
Clin Med (Lond). 2017 Apr;17(2):99-100. doi: 10.7861/clinmedicine.17-2-99.
本文引用的文献
1
Functional Esophageal Disorders.
Gastroenterology. 2016 Feb 15. doi: 10.1053/j.gastro.2016.02.012.
2
Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.
Neurogastroenterol Motil. 2015 Nov;27(11):1667-74. doi: 10.1111/nmo.12666. Epub 2015 Sep 4.
3
Effects of anxiety and depression in patients with gastroesophageal reflux disease.
Clin Gastroenterol Hepatol. 2015 Jun;13(6):1089-95.e1. doi: 10.1016/j.cgh.2014.11.034. Epub 2014 Dec 9.
4
Proton pump inhibitors reduce the size and acidity of the acid pocket in the stomach.
Clin Gastroenterol Hepatol. 2014 Jul;12(7):1101-1107.e1. doi: 10.1016/j.cgh.2014.04.003. Epub 2014 Apr 12.
5
Response of the airways and autonomic nervous system to acid perfusion of the esophagus in patients with asthma: a laboratory study.
BMC Pulm Med. 2013 Jun 2;13:33. doi: 10.1186/1471-2466-13-33.
6
Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period.
Gut. 2012 Dec;61(12):1670-7. doi: 10.1136/gutjnl-2011-300926. Epub 2012 Jan 20.
7
Systematic review: Patterns of proton pump inhibitor use and adherence in gastroesophageal reflux disease.
Clin Gastroenterol Hepatol. 2012 Feb;10(2):109-16. doi: 10.1016/j.cgh.2011.07.008. Epub 2011 Jul 23.
8
Insights into gastroesophageal reflux disease-associated dyspeptic symptoms.
Clin Gastroenterol Hepatol. 2011 Oct;9(10):824-33. doi: 10.1016/j.cgh.2011.05.015. Epub 2011 May 20.
9
Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole.
BMC Gastroenterol. 2011 May 11;11:52. doi: 10.1186/1471-230X-11-52.
10
Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.
Am J Gastroenterol. 2011 Aug;106(8):1419-25; quiz 1426. doi: 10.1038/ajg.2011.146. Epub 2011 May 3.
Zotero 插件